Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedJul 10, 2013MitomycinLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-657-2013Class IITerminatedJul 10, 2013Mitomycin 0.04% solutionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-656-2013Class IITerminatedJul 10, 2013Methylcobalamin 12.5 mg/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-655-2013Class IITerminatedJul 10, 2013Methylcobalamin 1250 mcg/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-654-2013Class IITerminatedJul 10, 2013Methionine/Choline/Inositol/ B-12Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-653-2013Class IITerminatedJul 10, 2013Medroxyprogesterone 50 mg/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-652-2013Class IITerminatedJul 10, 2013Medroxyprogesterone 150 mg/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-651-2013Class IITerminatedJul 10, 2013Latanoprost 0.025% eye dropLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-650-2013Class IITerminatedJul 10, 2013Laser ophthalmic dropsLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-649-2013Class IITerminatedJul 10, 2013Itraconazole 1% eye ointmentLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-648-2013Class IITerminatedJul 10, 2013Injection vehicleLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-647-2013Class IITerminatedJul 10, 2013Hydroxyprogesterone 250 mg/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-646-2013Class IITerminatedJul 10, 2013HCG 500 units/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-645-2013Class IITerminatedJul 10, 2013HCG 2000 units/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-644-2013Class IITerminatedJul 10, 2013HCG 1000 units/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-643-2013Class IITerminatedJul 10, 2013Gentamicin buffered 36.4 mg/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-642-2013Class IITerminatedJul 10, 2013Estradiol Valerate 30 mg/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-641-2013Class IITerminatedJul 10, 2013Estradiol Valerate 20 mg/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-640-2013Class IITerminatedJul 10, 2013Estradiol Cypionate 5 mg/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.Clinical Specialties Compounding Pharmacy · D-639-2013Class IITerminatedJul 10, 2013Diazepam 5 mg/mlLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.Clinical Specialties Compounding Pharmacy · D-638-2013Class IITerminatedJul 10, 2013Cyclosporine 2% ophthalmicLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.Clinical Specialties Compounding Pharmacy · D-637-2013Class IITerminatedJul 10, 2013Cyclosporine 1% ophthalmic dropsLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.Clinical Specialties Compounding Pharmacy · D-636-2013Class IITerminatedJul 10, 2013Cataract dropsLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.Clinical Specialties Compounding Pharmacy · D-635-2013Class IITerminatedJul 10, 2013Acetylcysteine 2 % SolutionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.Clinical Specialties Compounding Pharmacy · D-634-2013Class IITerminatedJul 10, 2013Acetylcysteine 20 % solutionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.Clinical Specialties Compounding Pharmacy · D-633-2013Class IITerminatedJul 10, 2013Acetylcysteine 10 % SolutionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesClinical Specialties Compounding Pharmacy · D-632-2013Class IIITerminatedJul 10, 2013PremproFailed Dissolution Specifications: Pfizer Inc. (Pfizer) is recalling PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) because certain lots for this...Pfizer Inc. · D-631-2013Class IIITerminatedJul 10, 2013PremproFailed Dissolution Specifications: Pfizer Inc. is recalling PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) because certain lots for this product may...Pfizer Inc. · D-630-2013Class IITerminatedJul 10, 2013Metronidazole Injection USPLack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the...Baxter Healthcare Corp. · D-629-2013Class IITerminatedJul 10, 2013Sodium Chloride InjectionLack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the...Baxter Healthcare Corp. · D-628-2013Class IITerminatedJul 10, 2013Lidocaine Hydrochloride and 5% Dextrose InjectionLack of Assurance of Sterilty: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the...Baxter Healthcare Corp. · D-627-2013Class IITerminatedJul 10, 2013Heparin Sodium and 0.9% Sodium Chloride InjectionLack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the...Baxter Healthcare Corp. · D-626-2013Class IITerminatedJul 10, 20135% Dextrose InjectionLack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the...Baxter Healthcare Corp. · D-625-2013Class IITerminatedJul 10, 20130.9% Sodium Chloride InjectionLack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the...Baxter Healthcare Corp. · D-624-2013Class IITerminatedJul 3, 20130.9% Sodium Chloride InjectionLabeling Wrong Barcode; It may display wrong product code reflecting 0.9% Sodium Chloride Injection , USP 100 mL in MINI-BAG Plus container instead of 50 mL.Baxter Healthcare Corp. · D-623-2013Class IITerminatedJul 3, 2013INK-EEZE Tattoo Black Label Numbing SprayMarketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed without an approved NDA/ANDA. Lidocaine 5% is an...Indelicare LLC · D-622-2013Class IITerminatedJul 3, 2013INK-EEZE Tattoo Numbing SprayMarketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed without an approved NDA/ANDA. Lidocaine 5% is an...Indelicare LLC · D-621-2013Class IITerminatedJul 3, 2013Pure-Aid Allergy ReliefLabeling: Not Elsewhere Classified; foil label on immediate blister pack indicates active ingredient as Chlorpheniramine rather than DiphenhydramineKareway Product Inc · D-620-2013Class IITerminatedJul 3, 20130.9% Sodium Chloride InjectionLack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.Hospira Inc. · D-619-2013Class IITerminatedJul 3, 20131.5% Glycine IrrigationLack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.Hospira Inc. · D-618-2013

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.